UCB shares 21 scientific abstracts, including the presentation of positive primary efficacy and safety results from a phase 3 study of FINTEPLA ® (fenfluramine) 1 in CDD, marking the third ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback